FDA approves Movantik for opioid-induced constipation
The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Chronic Pain | Constipation | Food and Drug Administration (FDA) | Oral Cancer | Pain